Publication: 2637

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer
      QxMD      Google Scholar   
Citation:
JAMA vol 317 (23) 2392-401
Year:
2017
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
6
Parents:
2137   2202   2225  
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, CA180799, CA180820, CA180826, U10CA032291, U10CA041287, U10CA047559, U10CA077597, U10CA077651, U10CA077658, U10CA138561, U10CA180790, U10CA180791, U10CA180795, U10CA180830, U10CA180836, U10CA180838, U10CA180850, U10CA180867, U10CA180888, R01 CA149222, U10 CA180821, U10 CA180795, U10 CA180836, U10 CA180791, U10 CA180850, U10 CA180790, U10 CA180882, U10 CA180820, U10 CA180799, U10 CA180867, U10 CA180838, U10 CA180888, U10 CA180830  
Corr. Author:
 
Authors:
                                               
Networks:
CA011, CA824, LAPS-IL036, LAPS-IL057, LAPS-IN007, LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-NY016, LAPS-OH007, LAPS-WI020, NC002, NC012, OR013   
Study
CALGB-80405
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
Article